151 related articles for article (PubMed ID: 19508370)
1. Aspects of B-cell non-Hodgkin's lymphoma development: a transition from immune-reactivity to malignancy.
Illes A; Varoczy L; Papp G; Wilson PC; Alex P; Jonsson R; Kovacs T; Konttinen YT; Zeher M; Nakken B; Szodoray P
Scand J Immunol; 2009 May; 69(5):387-400. PubMed ID: 19508370
[TBL] [Abstract][Full Text] [Related]
2. [Stages of lymphoid tissue ontogenesis and histogenesis of non-Hodgkin lymphoma].
Krivolanov IuA
Vopr Onkol; 2005; 51(4):417-26. PubMed ID: 16308972
[No Abstract] [Full Text] [Related]
3. B-cell development and maturation.
Rudin CM; Thompson CB
Semin Oncol; 1998 Aug; 25(4):435-46. PubMed ID: 9728594
[TBL] [Abstract][Full Text] [Related]
4. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation.
Suarez F; Lortholary O; Hermine O; Lecuit M
Blood; 2006 Apr; 107(8):3034-44. PubMed ID: 16397126
[TBL] [Abstract][Full Text] [Related]
5. Lymphoid malignancies: the dark side of B-cell differentiation.
Shaffer AL; Rosenwald A; Staudt LM
Nat Rev Immunol; 2002 Dec; 2(12):920-32. PubMed ID: 12461565
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic large cell lymphoma and acquired angioedema: a novel association?
Rossi D; Gaidano G
Ann Ital Med Int; 2002; 17(3):143-5. PubMed ID: 12402660
[No Abstract] [Full Text] [Related]
7. Human B lymphocytes and non-Hodgkin's lymphoma cells become polyploid in response to the protein kinase inhibitor SU6656.
Dussault N; Simard C; Néron S; Côté S
Blood Cells Mol Dis; 2007; 39(1):130-4. PubMed ID: 17434768
[TBL] [Abstract][Full Text] [Related]
8. Autoimmunity and lymphoma: tribulations of B cells.
Mackay IR; Rose NR
Nat Immunol; 2001 Sep; 2(9):793-5. PubMed ID: 11526388
[No Abstract] [Full Text] [Related]
9. Characterization of antibodies directed against the immunoglobulin light kappa chain variable chain region (VK) of hepatitis C virus-related type-II mixed cryoglobulinemia and B-cell proliferations.
de Re V; Simula MP; Pavan A; Garziera M; Marin D; Dolcetti R; de Vita S; Sansonno D; Geremia S; Toffoli G
Ann N Y Acad Sci; 2009 Sep; 1173():152-60. PubMed ID: 19758144
[TBL] [Abstract][Full Text] [Related]
10. CD8 expression in B-cell non-Hodgkin's lymphomas.
Carulli G; Cannizzo E; Marini A; Rossi A; Baccelli E; Petrini M
Ann Hematol; 2008 Jul; 87(7):577-9. PubMed ID: 18327585
[No Abstract] [Full Text] [Related]
11. Host immune response in B-cell lymphomas: friend or foe?
Juszczyński P; Nowak J; Warzocha K
Arch Immunol Ther Exp (Warsz); 2008; 56(4):245-55. PubMed ID: 18726146
[TBL] [Abstract][Full Text] [Related]
12. Infectious agents and lymphoma development: molecular and clinical aspects.
Ferreri AJ; Ernberg I; Copie-Bergman C
J Intern Med; 2009 Apr; 265(4):421-38. PubMed ID: 19298458
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C and lymphoproliferative disorders: from mixed cryoglobulinemia to non-Hodgkin's lymphoma.
Martyak LA; Yeganeh M; Saab S
Clin Gastroenterol Hepatol; 2009 Aug; 7(8):900-5. PubMed ID: 19362606
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory cells and immune microenvironment in malignant lymphoma.
de Jong D; Enblad G
J Intern Med; 2008 Dec; 264(6):528-36. PubMed ID: 19017177
[TBL] [Abstract][Full Text] [Related]
15. Histopathology of Hodgkin's lymphoma.
Eberle FC; Mani H; Jaffe ES
Cancer J; 2009; 15(2):129-37. PubMed ID: 19390308
[TBL] [Abstract][Full Text] [Related]
16. [New diagnostic approaches in malignant B-cell lymphomas].
Benattar L; Flandrin G
Ann Biol Clin (Paris); 2003; 61(5):513-9. PubMed ID: 14671748
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in cutaneous lymphomas.
Dummer R; Asagoe K; Cozzio A; Burg G; Doebbeling U; Golling P; Fujii K; Urosevic M
J Dermatol Sci; 2007 Dec; 48(3):157-67. PubMed ID: 17964121
[TBL] [Abstract][Full Text] [Related]
18. Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects.
Ratanatharathorn V; Pavletic S; Uberti JP
Cancer Treat Rev; 2009 Dec; 35(8):653-61. PubMed ID: 19682801
[TBL] [Abstract][Full Text] [Related]
19. Higher Incidence of B Cell Malignancies in Primary Immunodeficiencies: A Combination of Intrinsic Genomic Instability and Exocytosis Defects at the Immunological Synapse.
Mastio J; Saeed MB; Wurzer H; Krecke M; Westerberg LS; Thomas C
Front Immunol; 2020; 11():581119. PubMed ID: 33240268
[TBL] [Abstract][Full Text] [Related]
20. BiovaxID, a personalized therapeutic vaccine against B-cell lymphomas.
Reinis M
Curr Opin Mol Ther; 2008 Oct; 10(5):526-34. PubMed ID: 18830928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
